[The results of cobalt therapy for carcinoma of the larynx (author's transl)].
The effectiveness of cobalt therapy for carcinoma of the larynx in demonstrated by the results obtained: 53% overall survival at 5 years, with 66% for carcinomas of the glottis, and 48% for supra-glottal lésions. The dose-time ratio used was adapted to the tumor category and to the individual reactivity of the patients, local control being obtained in 100, 87, 65 and 25% for T1, T2, T3 and T4 tumours respectively.
D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D012189:Retrospective Studies
D003037:Cobalt Radioisotopes
Résultats de la télécobalthérapie pour le cancer du larynx.